Add Company
Join Now

Ona Therapeutics Revenue and Competitors

License our Company Data API

Barcelona, Spain

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Ona Therapeutics's estimated annual revenue is currently $5.3M per year.(i)
  • Ona Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Ona Therapeutics has 34 Employees.(i)
  • Ona Therapeutics grew their employee count by 6% last year.

Ona Therapeutics's People

NameTitleEmail/Phone
1
Research assistantReveal Email/Phone
2
Research AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.4M41N/AN/AN/A
#2
$0.9M6N/AN/AN/A
#3
$5.9M38N/AN/AN/A
#4
$47M30318%N/AN/A
#5
$9.5M6111%N/AN/A
#6
$46.7M30125%N/AN/A
#7
$1.7M11-8%N/AN/A
#8
$3.7M24-11%N/AN/A
#9
$4.2M2713%N/AN/A
#10
$5.3M346%N/AN/A
Add Company

What Is Ona Therapeutics?

Ona Therapeutics is a biotech company, spin-off of ICREA and IRB, specialized in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$5.3M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ona Therapeutics News

2022-04-20 - -$0.24 Earnings Per Share Expected for Context Therapeutics ...

Equities research analysts expect Context Therapeutics Inc. ... Its lead product candidate is onapristone extended release (ONA-XR),...

2022-04-06 - Context Therapeutics® Announces Encouraging Preclinical Data from Two Programs to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2022

Lead clinical-stage oral progesterone receptor (PR) antagonist ONA-XR demonstrates strong efficacy across multiple PR+ solid tumor models.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.9M3448%N/A
#2
$6M3448%N/A
#3
$4.6M3479%N/A
#4
$3.9M34-15%N/A
#5
$4.1M3521%N/A